行动 C 臂市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球行动C臂市场规模达16亿美元，预计2034年将以5.5%的复合年增长率成长至28亿美元。移动式C臂系统是先进的便携式成像工具，旨在在诊断和手术过程中提供即时X光可视化。其提供即时影像回馈的能力在支持临床决策、提高手术准确性和改善患者预后方面发挥着至关重要的作用。心血管疾病、癌症和神经系统疾病等慢性疾病在全球日益加重，这是市场扩张的关键驱动力，因为这些疾病通常需要精确的影像进行诊断和治疗。微创手术需求的不断增长，加上影像技术的进步，进一步推动了已开发地区和发展中地区对高性能移动C臂的需求。医院和医疗机构正在持续投资这些系统，以确保更快的诊断速度和更高的手术效率，尤其是在紧急情况下。随着全球（尤其是新兴市场）医疗保健基础设施不断现代化，行动 C 臂因其便携性、精确性和易用性而成为现代手术工作流程不可或缺的一部分。

就侦测器类型而言，市场细分为影像增强型C臂和平板侦测器 (FPD) C臂。平板侦测器C臂可提供更佳的影像品质、更高的对比度解析度和增强的解剖视觉化效果，使其成为脊椎手术、骨科创伤和心血管介入等复杂手术的理想选择。这些侦测器还具有更高的辐射效率，能够以更低的剂量产生更清晰的影像，从而增强患者和操作员的安全性。基于FPD的系统透过提供更宽广、更稳定的影像视野，进一步减少了工作流程中断，从而减少了手术期间重新定位的需要。向平板探测器技术的转变在提高手术精度和简化成像流程方面发挥着至关重要的作用。

根据输出功率，市场分为高功率C臂（11kW-25kW）和低功率C臂（2kW-10kW）。高功率C臂市场在2024年达到9.898亿美元，占61%的市占率。这些高容量系统是需要深层组织成像和延长成像时间的复杂手术的首选。它们能够在神经血管、骨科和心血管手术等高要求的介入手术中提供高解析度结果，使其成为手术室的必备设备。它们在高负荷下的出色性能也使其非常适合用于更大的解剖区域，确保在复杂的手术过程中获得更清晰的可视化效果。

从设计角度来看，市场分为整合系统和独立配置系统。整合式行动C臂占据主导地位，2024年的市占率为71.1%。这些系统将所有成像组件整合到一个紧凑的单元中，在拥挤或空间受限的临床环境中尤其有用。其一体化设计简化了操作，减少了设定时间，并提高了工作流程效率。整合系统的便利性在急诊和ICU等高压医疗环境中尤其有用，因为在这些环境中，快速取得影像至关重要。

按应用领域划分，移动式C臂市场涵盖骨科和创伤、神经内科、心臟病学、胃肠病学、牙科、肿瘤学及其他领域。 2024年，骨科和创伤领域以3.523亿美元的收入领先市场。事故相关损伤和年龄相关骨病变的增多，提升了即时术中影像的需求。移动式C臂能够精确可视化骨骼排列和植入物位置，显着改善手术效果并最大限度地减少併发症。即时3D成像和辐射剂量控制等技术进步，进一步支持了这些系统在骨科护理中的应用。

根据最终用途，市场细分为医院、诊断中心和其他医疗保健机构。医院在2024年以8.187亿美元的收入引领市场。医院提供的广泛服务和高患者吞吐量需要可靠、高效能的影像系统。医院的移动C臂应用于骨科、泌尿科和心血管科等多个科室。医院数量的增长，尤其是在城市地区，直接导致了设备需求的增长。此外，医院配备训练有素的专业人员，提高了行动C臂系统的安全性和有效性，从而促进了更高的采用率。

从区域来看，北美市场占据主导地位，2024 年市场规模达 5.637 亿美元，预计到 2034 年将达到 9.343 亿美元。美国占了大部分份额，2024 年达到 4.975 亿美元。需要外科手术介入的慢性病发生率不断上升，促使该地区的医院和诊所投资先进的影像技术。主要行业参与者的强大影响力以及先进的医疗基础设施进一步推动了该地区市场的成长。

行动C臂市场竞争激烈，前四大厂商占全球近45%的市场。主要公司包括通用电气医疗科技公司、西门子医疗公司、荷兰皇家飞利浦公司和奇目成像公司。这些公司透过持续创新、强大的全球分销和策略监管规划来保持市场主导地位。与研究机构和公共卫生组织的合作也支持他们致力于将下一代影像解决方案推向市场。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 外科手术数量不断增加
    • 慢性病盛行率上升
    • 移动式C臂机的技术进步
    • 微创手术需求不断成长
  • 产业陷阱与挑战
    • 移动式 C 臂机器成本高
    • 缺乏熟练的医疗保健专业人员
• 成长潜力分析
• 监管格局
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 各国应对措施
  • 对产业的影响
    • 供应方影响（製造成本）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
    • 需求面影响（消费者成本）
      • 价格传导至终端市场
      • 市占率动态
      • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按探测器类型，2021 年至 2034 年

• 主要趋势
• 平板侦测器 (FPD) C 臂
  • 类型
    • 非晶硅（a-Si）探测器
    • 铟镓锌氧化物 (IGZO) 侦测器
    • 互补金属氧化物半导体 (CMOS) 侦测器
  • 尺寸
    • 20厘米×20厘米
    • 26厘米×26厘米
    • 30厘米 x 30厘米
    • 其他尺寸
• 影像增强器C臂

第六章：市场估计与预测：按发电量，2021 年至 2034 年

• 主要趋势
• 低功率 C 臂（2kW - 10kW）
• 高功率 C 臂（11kW – 25kW）

第七章：市场估计与预测：依设计配置，2021 年至 2034 年

• 主要趋势
• 整合系统
• 单独的配置系统

第 8 章：市场估计与预测：按应用，2021 年至 2034 年

• 主要趋势
• 骨科和创伤
• 心臟病学
• 神经病学
• 胃肠病学
• 肿瘤学
• 牙科
• 其他应用

第九章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 诊断中心
• 其他最终用户

第十章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：公司简介

• Fujifilm Holdings Corporation
• GE HealthCare Technologies
• Genoray Co
• Hologic
• Koninklijke Philips
• Nanjing Perlove Medical Equipment Co
• Shimadzu Corporation
• Siemens Healthineers
• SternMed
• Stephanix
• Turner Imaging Systems
• Ziehm Imaging

The Global Mobile C-Arm Market was valued at USD 1.6 billion in 2024 and is estimated to grow at a CAGR of 5.5% to reach USD 2.8 billion by 2034. Mobile C-arm systems are advanced, portable imaging tools designed to deliver real-time X-ray visualization during diagnostic and surgical procedures. Their ability to provide immediate imaging feedback plays a vital role in supporting clinical decisions, improving surgical accuracy, and enhancing patient outcomes. The rising global burden of chronic illnesses such as cardiovascular conditions, cancer, and neurological disorders is a key driver of market expansion, as these conditions often require precise imaging for diagnosis and treatment. Increasing demand for minimally invasive surgeries, coupled with advancements in imaging technology, is further boosting the need for high-performance mobile C-arm units in both developed and developing regions. Hospitals and healthcare facilities are continuously investing in these systems to ensure faster diagnostics and improved surgical efficiency, particularly in emergency settings. As healthcare infrastructure continues to modernize globally, especially in emerging markets, mobile C-arms are becoming integral to modern surgical workflows due to their portability, precision, and ease of use.

In terms of detector type, the market is segmented into image intensifier C-arms and flat panel detector (FPD) C-arms. Flat panel detector C-arms offer improved image quality, higher contrast resolution, and enhanced anatomical visualization. This makes them ideal for intricate procedures such as spinal surgeries, orthopedic trauma, and cardiovascular interventions. These detectors also offer better radiation efficiency, producing clearer images at lower doses, which enhances patient and operator safety. FPD-based systems further reduce workflow interruptions by providing a broader and more stable imaging field, limiting the need for repositioning during procedures. The shift toward flat panel detector technology is playing a crucial role in improving surgical precision and streamlining imaging processes.

Based on power output, the market is divided into high-powered C-arms (11kW-25kW) and low-powered C-arms (2kW-10kW). The high-powered C-arm segment accounted for USD 989.8 million in 2024, capturing 61% of the market. These high-capacity systems are preferred for complex procedures requiring deep tissue imaging and extended imaging durations. Their ability to deliver high-resolution results during demanding interventions, such as neurovascular, orthopedic, and cardiovascular surgeries, has made them essential equipment in operating rooms. Their performance under high workloads also makes them well-suited for use in larger anatomical regions, ensuring clearer visualizations during intricate procedures.

Design-wise, the market is categorized into integrated systems and separate configuration systems. Integrated mobile C-arms dominated with a 71.1% share in 2024. These systems combine all imaging components into a single compact unit, making them especially valuable in crowded or space-constrained clinical environments. Their all-in-one design simplifies operation, reduces setup time, and improves workflow efficiency. The convenience of integrated systems is especially useful in high-pressure medical environments such as emergency departments and ICUs, where rapid imaging access is essential.

By application, the mobile C-arm market covers orthopedics and trauma, neurology, cardiology, gastroenterology, dental, oncology, and other uses. The orthopedics and trauma segment led the market in 2024 with USD 352.3 million in revenue. The increasing volume of accident-related injuries and age-related bone disorders has elevated the demand for real-time intraoperative imaging. Mobile C-arms offer accurate visualization of bone alignment and implant placement, significantly enhancing surgical outcomes and minimizing complications. Technological advancements, such as real-time 3D imaging and radiation dose control, are further supporting the use of these systems in orthopedic care.

Based on end use, the market is segmented into hospitals, diagnostic centers, and other healthcare settings. Hospitals led the market with USD 818.7 million in revenue in 2024. Their wide service offerings and high patient throughput necessitate reliable, high-performance imaging systems. Mobile C-arms in hospitals are used across various specialties including orthopedics, urology, and cardiovascular care. The growing number of hospitals, especially in urban areas, directly contributes to increasing equipment demand. Additionally, the availability of trained professionals in hospitals enhances the safe and effective use of mobile C-arm systems, encouraging higher adoption rates.

Regionally, North America dominated the market with USD 563.7 million in 2024 and is projected to reach USD 934.3 million by 2034. The United States contributed the majority share, recording USD 497.5 million in 2024. The growing incidence of chronic conditions requiring surgical interventions is pushing hospitals and clinics in the region to invest in state-of-the-art imaging technology. The strong presence of key industry players and the availability of advanced healthcare infrastructure further drive market growth in the region.

The mobile C-arm market is highly competitive, with the top four players accounting for nearly 45% of the global share. Key companies include GE HealthCare Technologies, Siemens Healthineers, Koninklijke Philips, and Ziehm Imaging. These firms maintain market dominance through continuous innovation, strong global distribution, and strategic regulatory planning. Collaborations with research institutions and public health organizations also support their efforts in bringing next-generation imaging solutions to the market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing number of surgical procedures
    • 3.2.1.2 Rising prevalence of chronic diseases
    • 3.2.1.3 Technological advancements of mobile C-arm machines
    • 3.2.1.4 Rising demand for minimally invasive procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with mobile C-arm machines
    • 3.2.2.2 Dearth of skilled healthcare professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Country-wise response
  • 3.5.2 Impact on the industry
    • 3.5.2.1 Supply-side impact (Cost of Manufacturing)
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (Cost to Consumers)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Detector Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Flat panel detector (FPD) C-arms
  • 5.2.1 Type
    • 5.2.1.1 Amorphous silicon (a-Si) detectors
    • 5.2.1.2 Indium gallium zinc oxide (IGZO) detectors
    • 5.2.1.3 Complementary metal-oxide semiconductor (CMOS) detectors
  • 5.2.2 Size
    • 5.2.2.1 20 cm × 20 cm
    • 5.2.2.2 26 cm × 26 cm
    • 5.2.2.3 30 cm x 30 cm
    • 5.2.2.4 Other sizes
• 5.3 Image intensifier C-arms

Chapter 6 Market Estimates and Forecast, By Power Output, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Low-powered C-arms (2kW - 10kW)
• 6.3 High-powered C-arms (11kW – 25kW)

Chapter 7 Market Estimates and Forecast, By Design Configuration, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Integrated systems
• 7.3 Separate configuration systems

Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Orthopedics and trauma
• 8.3 Cardiology
• 8.4 Neurology
• 8.5 Gastroenterology
• 8.6 Oncology
• 8.7 Dental
• 8.8 Other applications

Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Diagnostic centers
• 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Fujifilm Holdings Corporation
• 11.2 GE HealthCare Technologies
• 11.3 Genoray Co
• 11.4 Hologic
• 11.5 Koninklijke Philips
• 11.6 Nanjing Perlove Medical Equipment Co
• 11.7 Shimadzu Corporation
• 11.8 Siemens Healthineers
• 11.9 SternMed
• 11.10 Stephanix
• 11.11 Turner Imaging Systems
• 11.12 Ziehm Imaging